35 participants
SM-1 Combined With Temozolomide in Subjects With Refractory or Recurrent High-Grade Gliomas
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-09
- Start Date:
- 2022-09-19
- Completion:
- 2024-04-22
Conditions
- Glioma
- Glioblastomas (GBM)
- High Grade Gliomas
Interventions
- DRUG
No Results Yet